Details

Last Funding Type

Series C

Last Funding Money Raised

$3.60M

Founded date

Jan 1, 2011

Number Of Employee

11 - 50

Operating Status

Close

TOMA Biosciences is a genomics company that provides physicians with information to optimize treatment for cancer patients. TOMA’s proprietary sequencing solution turns the latest next=generation sequencing (NGS) technology into a powerful digital tool to detect the most clinically meaningful changes in a patient’s tumor DNA. Physicians use this important data to optimize treatment for their patients.

TOMA technology enables laboratories to uncover the DNA alterations in cancer cells to provide meaningful data for researchers and clinicians seeking the optimal treatment options for their patients. The company is a commercial-stage private venture-backed company headquartered in Foster City, California.